Retatrutide Dosage Guide

Complete guide to Retatrutide dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Clinical trials used doses from 1mg to 12mg weekly. Optimal dosing still being determined in ongoing Phase 3 trials.

Administration Method

Subcutaneous injection once weekly. Currently only available through clinical trials - not yet FDA approved.

Side Effects to Monitor

Similar GI effects to other incretin-based therapies: nausea, diarrhea, vomiting, constipation. Dose-dependent severity.

Safety Considerations & Risks

Still investigational - full safety profile being established. Expected similar warnings to GLP-1 class regarding thyroid, pancreatitis, and gallbladder.